china sxt pharmaceuticals, inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional chinese medicine piece tablets (tcmp) in china. it offers advanced, fine, and regular tcmp products, such as chenxiang, sanqifen, hongqi, sumu, jiangxiang, cuyanhusuo, xiatianwu, luxuejing, xuejie, chaosuanzaoren, hongqumi, chuanbeimu, huangshukuihua, wuweizi, dingxiang, renshen, qingguo, juemingzi, and sharen. the company provides its products under the suxuantang, hui chun tang, and tong ren tang brands. as of may 2, 2020, it served 116 pharmaceutical companies, 56 pharmacies, and 76 hospitals. the company was founded in 2005 and is based in taizhou, china.
Company profile
Ticker
SXTC
Exchange
Website
CEO
Feng Zhou
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
SXTC stock data
Latest filings (excl ownership)
6-K
Management’s Discussion and Analysis of Financial Condition and Results of Operations
5 Apr 24
S-8
Registration of securities for employees
11 Jan 24
20-F
2023 FY
Annual report (foreign)
31 Jul 23
UPLOAD
Letter from SEC
2 Jun 23
20-F/A
2022 FY
Annual report (foreign) (amended)
19 May 23
CORRESP
Correspondence with SEC
13 Apr 23
UPLOAD
Letter from SEC
31 Mar 23
424B7
Prospectus with selling stockholder info
24 Mar 23
6-K
Report of Foreign Private Issuer
23 Mar 23
6-K
Current Report
28 Feb 23
Latest ownership filings
SC 13G/A
Forsakringsaktiebolaget Avanza Pension
9 Feb 24
SC 13G
Forsakringsaktiebolaget Avanza Pension
9 Feb 24
SC 13G
Streeterville Capital LLC
29 Mar 23
SC 13G/A
Streeterville Capital LLC
29 Mar 23
SC 13G/A
Lind Global Fund II LP
13 Feb 23
SC 13D/A
Zhou Albert Feng
30 Jan 23
SC 13G
Streeterville Capital LLC
25 Aug 22
SC 13G
Lind Global Fund II LP
21 Jan 22
SC 13G/A
Ayrton Capital LLC
16 Feb 21
SC 13G/A
Hudson Bay Capital Management LP
11 Feb 21
Financial summary
Quarter (USD) | Mar 23 | Mar 22 | Mar 21 | Mar 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Mar 23 | Mar 22 | Mar 21 | Mar 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q2 2023
13.3% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 5 |
Opened positions | 2 |
Closed positions | 2 |
Increased positions | 0 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 8.64 mm |
Total shares | 1.88 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Zhou Albert Feng | 1.73 mm | $1.33 mm |
Acadian Asset Management | 105.04 k | $23.00 k |
Two Sigma Securities | 20.56 k | $4.83 mm |
Renaissance Technologies | 10.54 k | $2.00 k |
Cetera Advisor Networks | 10.42 k | $2.45 mm |
Proequities | 0.00 | $0.00 |
News
12 Health Care Stocks Moving In Thursday's After-Market Session
18 Apr 24
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
17 Apr 24
12 Health Care Stocks Moving In Wednesday's Intraday Session
17 Apr 24
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
17 Apr 24
Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket
17 Apr 24